创伤性脊髓损伤急性期前列腺素E1对血管相关因子的调节和微循环功能的保护

背景:前列腺素E1被证明在血管扩张、炎症、白细胞迁移和黏附中发挥调节作用,但其对创伤性脊髓损伤后脊髓微循环的作用尚缺乏深入的研究。目的:探讨在大鼠创伤性脊髓损伤急性期给予前列腺素E1对血管相关因子的调节和微循环功能的保护作用机制。方法:将72只雌性SD大鼠随机分为3组(n=24),即假手术组、脊髓损伤组、前列腺素E1组。后两组用Allen’s打击法建立脊髓损伤的体内模型,前列腺素E1组大鼠在脊髓损伤后15 min内立即尾静脉注射脂质前列腺素E110μg/kg。分别在损伤后2,24 h测定脊髓微循环血流量和血氧饱和度、脊髓微血管直径和面积、脊髓含水量、血管功能调节因子(血浆血管性血友病因子、血栓素A2、前列环素、内皮素1)和炎症因子(肿瘤坏死因子α、白细胞介素1β)的表达。结果与结论:①脊髓损伤后2 h,前列腺素E1组大鼠的脊髓微血管直径及面积、脊髓微循环血流量和血氧饱和度均高于脊髓损伤组(P<0.05),脊髓含水量低于脊髓损伤组(P<0.05),血浆血管性血友病因子、脊髓组织血栓素A2/前列环素及内皮素1质量浓度均低于脊髓损伤组(P<0.05);②脊髓损伤后24 h,前列腺素E1组大鼠的脊髓微血管面积、血流量和血氧饱和度均高于脊髓损伤组(P<0.05),脊髓含水量低于脊髓损伤组(P<0.05),血浆血管性血友病因子、脊髓组织血栓素A2/前列环素及内皮素1、肿瘤坏死因子α、白细胞介素1β的质量浓度均低于脊髓损伤组(P<0.05);③脊髓损伤组大鼠损伤后24 h的脊髓微血管直径及面积、脊髓微循环血流量和血氧饱和度均高于损伤后2 h(P<0.05),血浆血管性血友病因子、脊髓组织血栓素A2/前列环素、肿瘤坏死因子α、白细胞介素1β的质量浓度均高于损伤后2 h(P<0.05),但是脊髓组织内皮素1质量浓度低于损伤后2 h(P<0.05);④前列腺素E1组大鼠损伤后24 h的脊髓微循环血流量和血氧饱和度低于损伤后2 h(P<0.05),脊髓微血管直径及面积、脊髓含水量高于损伤后2 h(P<0.05);⑤以上结果表明,脊髓损伤大鼠伤后即刻静脉给予前列腺素E1,可调节血管功能调节因子、炎症因子并改善脊髓损伤后脊髓微循环,这为寻找治疗急性脊髓损伤的药物提供了潜在的基础。

Correlations of the expression of Cx43,SCFFBXW7,p-cyclin E1(Ser73),p-cyclin E1(Thr77)and p-cyclin E1(Thr395)in colon cancer tissues

BACKGROUND Previous cellular studies have demonstrated that elevated expression of Cx43 promotes the degradation of cyclin E1 and inhibits cell proliferation through ubiquitination.Conversely,reduced expression results in a loss of this capacity to facilitate cyclin E degradation.The ubiquitination and degradation of cyclin E1 may be associated with phosphorylation at specific sites on the protein,with Cx43 potentially enhancing this process by facilitating the phosphorylation of these critical residues.AIM To investigate the correlation between expression of Cx43,SKP1/Cullin1/F-box(SCF)FBXW7,p-cyclin E1(ser73,thr77,thr395)and clinicopathological indexes in colon cancer.METHODS Expression levels of Cx43,SCFFBXW7,p-cyclin E1(ser73,thr77,thr395)in 38 clinical colon cancer samples were detected by immunohistochemistry and were analyzed by statistical methods to discuss their correlations.RESULTS Positive rate of Cx43,SCFFBXW7,p-cyclin E1(Ser73),p-cyclin E1(Thr77)and p-cyclin E1(Thr395)in detected samples were 76.32%,76.32%,65.79%,5.26%and 55.26%respectively.Positive expressions of these proteins were not related to the tissue type,degree of tissue differentiation or lymph node metastasis.Cx43 and SCFFBXW7(r=0.749),p-cyclin E1(Ser73)(r=0.667)and p-cyclin E1(Thr395)(r=0.457),SCFFBXW7 and p-cyclin E1(Ser73)(r=0.703)and p-cyclin E1(Thr395)(0.415)were correlated in colon cancer(P<0.05),and expressions of the above proteins were positively correlated in colon cancer.CONCLUSION Cx43 may facilitate the phosphorylation of cyclin E1 at the Ser73 and Thr195 sites through its interaction with SCFFBXW7,thereby influencing the ubiquitination and degradation of cyclin E1.

Clinical,laboratory,and therapeutic differences between immunoglobulin E-mediated and non-immunoglobulin E-mediated cow’s milk protein allergy in children

BACKGROUND Although breast milk is ideal for newborns,in some cases,it is replaced with cow’s milk,which contains proteins that increase the risk of cow’s milk protein allergy(CMPA).AIM To evaluate CMPA prevalence in Bahrain and compare clinical characteristics of children with immunoglobulin E(IgE)-and non-IgE-mediated CMPA.METHODS This retrospective cohort study examined children with CMPA diagnosed at the pediatric gastroenterology outpatient clinic of the Salmaniya Medical Complex,Bahrain,between 2014 and 2022,and assessed CMPA prevalence.Clinical presentations,laboratory findings,dietary modifications,and outcomes were compared between children with IgE-mediated and non-IgE-mediated CMPA.Categorical variables were compared using Fisher’s exact test or Pearson’sχ2 test,whereas continuous variables were compared using Student’s t-test or the Mann-Whitney U test.RESULTS Of 8332 patients,6022(72.3%)adhered to their appointment.Of them,618(10.3%)were suggested of having CMPA and 595(96.3%)were included;CMPA prevalence was 2%.Most patients were Bahraini(93.8%)and males(55.3%).Non-IgE-mediated type accounted for 77.3%cases and IgE-mediated type,22.7%.IgE-mediated CMPA presented more in boys(P=0.030),and later in life(5.1 months±4.5 months vs 4.2 months±4.2 months,P=0.016,95%CI:0.08-1.73),had more associated diseases(P<0.001);and presented with more cutaneous(P=0.024)and respiratory(P=0.003)manifestations,severe symptoms[rash/dry skin(P=0.031),facial swelling/angioedema(P=0.003),failure to thrive(P=0.013),apparent life-threatening event(P<0.001)],and positive physical findings(P=0.002)than non-IgE-mediated CMPA.Most patients were exclusively fed cow milk formula(50.3%).The amino acid-based formula(AAF)was most prescribed(60.5%)with no difference between the two types(P=0.173).Although breastfeeding was recommended to 49.6%,only 8.2%were exclusively breastfed.IgE-mediated CMPA was associated with a longer follow-up duration than non-IgE-mediated CMPA(17.3 months±14.0 months vs 13.5 months±13.4 months,P=0.005,95%CI:1.1-6.3).CONCLUSION This study revealed a high CMPA prevalence with clinical differences between both types that can influence treatment.AAF was most prescribed,while breastfeeding with dietary modification is rarely applied.

Q550E高强钢及焊接接头的疲劳裂纹扩展研究

焊接构造是钢桥的薄弱部位,在反复车辆荷载作用下,疲劳损伤正逐步成为影响桥梁服役安全的关键问题之一。以Q550E高强钢为研究对象,开展母材和对接焊缝接头的静力拉伸和疲劳裂纹扩展试验,建立母材及焊接连接件的疲劳裂纹增长模型,揭示了应力比对高强钢焊接节点疲劳裂纹扩展速率的影响规律;开展基于FRANC3D和ABAQUS的联合仿真模拟分析,通过敏感性分析明确关键影响参数。结果表明:随着应力比的增大,疲劳裂纹扩展速率参数m增大、lg C减小,应力强度因子门槛值减小;对接焊缝m值约为母材的2倍,对接焊缝裂纹门槛值大于母材,且对应力比更敏感;联合仿真方法可准确预测高强钢焊接接头疲劳寿命,高应力比下试件厚度和初始裂纹深度对疲劳扩展影响显著。

Cohort study on the treatment of BRAF V600E mutant metastatic colorectal cancer with integrated Chinese and western medicine

BACKGROUND Patients with BRAF V600E mutant metastatic colorectal cancer(mCRC)have a low incidence rate,poor biological activity,suboptimal response to conventional treatments,and a poor prognosis.In the previous cohort study on mCRC conducted by our team,it was observed that integrated Chinese and Western medicine treatment could significantly prolong the overall survival(OS)of patients with colorectal cancer.Therefore,we further explored the survival benefits in the population with BRAF V600E mutant mCRC.AIM To evaluate the efficacy of integrated Chinese and Western medicine in the treatment of BRAF V600E mutant metastatic colorectal cancer.METHODS A cohort study was conducted on patients with BRAF V600E mutant metastatic colorectal cancer admitted to Xiyuan Hospital of China Academy of Chinese Medical Sciences and Traditional Chinese Medicine Hospital of Xinjiang Uygur Autonomous Region from January 2016 to December 2022.The patients were divided into two cohorts.RESULTS A total of 34 cases were included,with 23 in Chinese-Western medicine cohort(cohort A)and 11 in Western medicine cohort(cohort B).The median overall survival was 19.9 months in cohort A and 14.2 months in cohort B,with a statistically significant difference(P=0.038,hazard ratio=0.46).The 1-3-year survival rates were 95.65%(22/23),39.13%(9/23),and 26.09%(6/23)in cohort A,and 63.64%(7/11),18.18%(2/11),and 9.09%(1/11)in cohort B,respectively.Subgroup analysis showed statistically significant differences in median OS between the two cohorts in the right colon,liver metastasis,chemotherapy,and first-line treatment subgroups(P<0.05).CONCLUSION Integrated Chinese and Western medicine can prolong the survival and reduce the risk of death in patients with BRAF V600E mutant metastatic colorectal cancer,with more pronounced benefits observed in patients with right colon involvement,liver metastasis,combined chemotherapy,and first-line treatment.

Liver as a new target organ in Alzheimer's disease:insight from cholesterol metabolism and its role in amyloid-beta clearance

Alzheimer's disease,the primary cause of dementia,is characterized by neuropathologies,such as amyloid plaques,synaptic and neuronal degeneration,and neurofibrillary tangles.Although amyloid plaques are the primary characteristic of Alzheimer's disease in the central nervous system and peripheral organs,targeting amyloid-beta clearance in the central nervous system has shown limited clinical efficacy in Alzheimer's disease treatment.Metabolic abnormalities are commonly observed in patients with Alzheimer's disease.The liver is the primary peripheral organ involved in amyloid-beta metabolism,playing a crucial role in the pathophysiology of Alzheimer's disease.Notably,impaired cholesterol metabolism in the liver may exacerbate the development of Alzheimer's disease.In this review,we explore the underlying causes of Alzheimer's disease and elucidate the role of the liver in amyloid-beta clearance and cholesterol metabolism.Furthermore,we propose that restoring normal cholesterol metabolism in the liver could represent a promising therapeutic strategy for addressing Alzheimer's disease.

Rising incidence of acute hepatitis A among adults and clinical characteristics in a tertiary care center of Pakistan

BACKGROUND For decades,hepatitis A virus(HAV)has been a leading cause of acute hepatitis among children and was less prevalent among adults.However,recently a paradigm shift has been observed in the epidemiology of HAV,as evident by cases of acute hepatitis due to HAV among adults.AIM To estimate frequency of HAV in acute viral hepatitis and compare characteristics in HAV and hepatitis E virus(HEV)infection.METHODS This was a trend analysis conducted at Aga Khan University Hospital Karachi(Sindh,Pakistan)from February 2024 to May 2024.Individuals aged 18 years and older diagnosed with acute viral hepatitis attributed to hepatotropic viruses in 2024 were reviewed.To compare the trend patients admitted with acute hepatitis during 2019-2023 were also reviewed.Data regarding clinical and laboratory parameters were recorded.The yearly trend of acute hepatitis due to HAV and HEV was analyzed,and comparative analysis was done between HAV and HEV cases among adults.RESULTS A total of 396 patients were found to have acute hepatitis during our study duration.HAV was diagnosed in 234 patients(59%)while 157 patients(39.6%)were found to have acute HEV infection.Additionally,acute hepatitis B virus infection was identified in 3 patients(0.7%),whereas acute hepatitis C virus infection was found in 2(0.5%)cases of acute hepatitis.Yearly trends showed increasing occurrence of HAV infection among adults over last 5 years.The patients with acute HAV were younger than patients with HEV(28 years±8 years vs 30 years±8 years;P<0.01).Higher levels of total bilirubin were seen in HEV infection,while higher levels of alanine transaminase were seen in HAV infection.However,a higher proportion of acute liver failure(ALF),coagulopathy,and mortality were observed in HEV.CONCLUSION An increase in acute hepatitis A cases among adults shows less severity than hepatitis E,highlighting the need for better sanitation,hygiene,and adult hepatitis A vaccination programs.

5E教学模式应用于宏观经济学课程教学探索

宏观经济学课程教学内容主要为西方经济理论,理论性较强,教学团队教师结构单一,教学方式较传统,鉴于此,基于5E教学模式,对宏观经济学的教学进行改革,主要包括立足中国国情讲中国故事,引入案例式教学,通过翻转课堂提高学生学习积极性,通过虚拟仿真教学实现学生对宏观经济运行的切身体验,旨在切实提高宏观经济学教学效果,培养高素质应用型人才。

Enterobacter cloacae Z0206细菌胞外多糖的体外抗氧化活性研究

本实验旨在对Enterobacter cloacae Z0206菌进行发酵培养,以制备胞外多糖,并对其体外抗氧化活性进行初步研究。通过产多糖菌E.cloacaeZ0206的深层发酵制备细菌胞外多糖,在此基础上对其清除DPPH自由基、超氧阴离子、抑制羟自由基的能力以及还原力等四个方面进行实验,评价其抗氧化活性。结果表明,深层发酵制备的E.cloacaeZ0206胞外多糖产量为6.62g/L,其在5mg/mL时对DPPH自由基和羟自由基的清除率分别达到61.57%和40.08%。提示E.cloacaeZ0206细菌胞外多糖具有显著的抗氧化能力,具有开发为抗氧化类食品或药品的潜力。

Enterobacter Cloacae Z0206细菌胞外富硒多糖的抗氧化活性

利用产多糖菌Enterobacter cloacae Z0206(E.cloacaeZ0206)的深层发酵法制备了E.cloacae Z0206细菌富硒多糖;测定了其还原能力和清除1,1-diphenyl-2-picrylhydrazyl(DPPH)自由基、超氧阴离子及羟自由基的能力.结果表明,通过深层富硒发酵、醇沉离心等制备富硒多糖SEPS的产量为9.28g/L,富硒量为2.314mg/g;E.cloacae Z0206富硒多糖对DPPH自由基和羟自由基具有较好的清除作用,在浓度为5g/L时对DPPH自由基和羟自由基的清除率分别为80.35%和84.26%,并具有较强的还原能力,但其对超氧阴离子自由基的清除能力较差.

Enterobacter cloacae B5产转糖基β-半乳糖苷酶发酵条件优化

β-半乳糖苷酶是一类非常重要的糖苷水解酶,已被广泛应用于食品工业降低乳制品中的乳糖含量.某些种类的β-半乳糖苷酶还具有转糖基活性,近年来被应用于合成低聚半乳糖和半乳糖苷化合物.通过单因子试验和正交试验,对肠杆菌Enterobacter cloacae B5产生转糖基β-半乳糖苷酶的培养基组成及发酵条件进行了优化.结果表明,以无机盐溶液I(CaCl20.011%、MnSO40.0001%、MgSO4.7H2O0.03%、KH2PO40.005%、FeSO4.7H2O0.003%)、乳糖1.5%、酵母粉2%、蛋白胨0.5%、起始pH8.5的培养基在25℃培养E.cloacaeB5菌株38h,产酶量达到最高值4.663UmL-1,大约是未优化时的3倍.通过优化产酶条件提高了全细胞酶源的酶活量,不仅为功能性低聚半乳糖的生产降低了成本,同时也为商业化β-半乳糖苷酶的大量提纯降低了成本.

聚丙烯酰胺降解菌株Enterobacter cloacae的分离鉴定

应用厌氧Hungate技术,从大庆油田聚合物配注站的熟化罐水溶液中分离到一株聚丙烯酰胺降解菌株.对该菌株进行形态、生理生化、分子生物学鉴定结果表明,菌株为G-,短杆状,无芽孢,最佳pH值为8.0,最适生长温度为40℃,具有硫酸盐还原功能,产H2S,严格厌氧,通过16S rDNA和16S^23S rDNA间隔区序列鉴定,菌株与Enterobacter cloacae有极高的相似性.初步鉴定为Enterobact-er中的新种,暂时命名为Enterobacter cloacae.红外光谱分析结果表明,菌株以聚丙烯酰胺为惟一碳源,菌株作用前后表面结构发生变化,分子链上的酰胺基水解成羧基,降解侧链,部分官能团发生改变,溶液黏度下降效果显著;GC-MS初步分析聚合物发生断链,低分子质量化合物除含双键、环氧和羰基的聚丙烯酰胺碎片外,大多属于一般丙烯酰胺低聚体的衍生物.

Rapid Identification and Subtyping of Enterobacter cloacae Clinical Isolates Using Peptide Mass Fingerprinting

Objective To establish a domestic database of Enterobacteria cloacae （E. cloacae）, and improve the identification efficiency using peptide mass fingerprinting. Methods Peptide mass fingerprinting was used for the identification and subtyping of E. cloacae. Eighty-seven strains, identified based on hsp60 genotyping, were used to construct and evaluate a new reference database. Results Compared with the original reference database, the identification efficiency and accuracy of the new reference database was greatly improved at the species level. The first super reference database for E. cloacae identification was also constructed and evaluated. Based on the super reference database and the main spectra projection dendrogram, E. cloacae strains were divided into two clades. Conclusion Peptide mass fingerprinting is a powerful method to identify and subtype E. cloacae, and the use of this method will allow us to obtain more information to understand the heterogeneous organism E. cloacae.

Candida cloacae长链脂肪酸醇氧化酶基因的克隆与表达

The cDNA encoding long-chain fatty-acid alcohol oxidase(FAO) was isolated by using RT-PCR method from Candida cloacae grown in a medium containing oleic acid. The cDNA of fatty-acid alcohol oxidase was cloned into expression plasmid pET17b under T7 promoter and then transformed into E.coli BL21/DE3. The molecular weight of the expressed protein was estimated to be approximately 64 kD by SDS-PAGE. The expressed protein had a specific catalytic activity of fatty-acid alcohol oxidase and its activity was 1090±116 U/ml medium. Northern blotting revealed that there was high expression of fao mRNA in Candida cloacae yeast grown in a medium containing oleic acid.

Candida cloacae源脂肪酸醇氧化酶基因的植物表达质粒构建及农杆菌转化研究

目的构建表达Candidacloacae源脂肪酸醇氧化酶基因的植物表达质粒及对农杆菌转化。方法脂肪酸醇氧化酶基因经RT-PCR扩增后直接克隆pET-17b载体,双酶切目的片断和植物表达载体,以T4连接酶将目的片断与载体相连接,电转化方式将重组质粒转入农杆菌。结果成功地将目的基因定向克隆到表达载体,并转入到农杆菌中。结论pET-17b载体可直接进行PCR扩增产物克隆;大分子量质粒(>12kb)可通过电转化方式有效导入农杆菌中。

益胃解毒方治疗慢性萎缩性胃炎的效果及对Cyclin E、Th17/Treg比值的影响分析

目的分析益胃解毒方治疗慢性萎缩性胃炎中的效果及对细胞周期蛋白E(Cyclin E)水平、辅助性T细胞(Th17)/调节性T细胞(Treg)比值的影响。方法选取2019年6月至2022年6月在河北省石家庄市中医院确诊的150例慢性萎缩性胃炎患者作为研究对象,按照随机数字表法分为益胃解毒方组、六君子汤组、益胃解毒方+六君子汤组,每组50例。益胃解毒方组使用益胃解毒方治疗,六君子汤组使用六君子汤治疗,益胃解毒方+六君子汤组使用益胃解毒方联合六君子汤治疗,均连续治疗24周。比较3组治疗效果、中医证候积分、Cyclin E水平、Th17/Treg比值、不良反应发生情况。结果益胃解毒方组治疗总有效率高于六君子汤组和益胃解毒方+六君子汤组,且益胃解毒方+六君子汤组高于六君子汤组,差异均有统计学意义(P<0.05)。治疗后3组各项中医证候积分低于治疗前,差异均有统计学意义(P<0.05)。治疗后益胃解毒方组各项中医证候积分低于六君子汤组和益胃解毒方+六君子汤组,且益胃解毒方+六君子汤组低于六君子汤组,差异均有统计学意义(P<0.05)。治疗后3组Cyclin E水平、Th17/Treg比值均低于治疗前,差异均有统计学意义(P<0.05)。治疗后益胃解毒方组Cyclin E水平、Th17/Treg比值低于六君子汤组和益胃解毒方+六君子汤组,且益胃解毒方+六君子汤组低于六君子汤组,差异均有统计学意义(P<0.05)。益胃解毒方组总不良反应发生率低于六君子汤组和益胃解毒方+六君子汤组,且益胃解毒方+六君子汤组低于六君子汤组,差异均有统计学意义(P<0.05)。结论益胃解毒方治疗慢性萎缩性胃炎效果显著,不仅能够改善患者临床症状,调节Cyclin E、Th17/Treg表达,还能减少不良反应发生,值得临床推广应用。

牛病毒性腹泻病毒E2蛋白的真核表达及间接ELISA抗体检测方法的建立

为建立检测牛病毒性腹泻病毒(Bovine viral diarrhea virus,BVDV)抗体的间接ELISA方法,利用昆虫细胞真核表达系统成功表达E2蛋白,将纯化后的E2蛋白作为包被抗原,用方阵滴定方法对影响ELISA的各个因素进行优化,并进行特异性、敏感性和重复性试验。结果表明,在昆虫细胞中表达了BVDV E2蛋白,Western blot证实目的蛋白可与BVDV阳性血清发生特异性反应。ELISA优化结果显示,E2蛋白最佳包被浓度为0.5μg/mL,最佳封闭液为1%明胶,最佳血清稀释度为1∶400,最佳血清作用方式为37℃作用30 min,酶标抗体的最佳作用方式为1∶2000稀释、37℃作用30 min,最佳底物作用时间为室温20 min,阳性临界值为OD 450≥0.423。与血清中和试验法进行比较,总符合率为97.8%,板内和板间重复性试验的变异系数均小于10%。该方法与牛常见病毒阳性血清均无交叉反应。说明建立的间接ELISA抗体检测方法特异性、敏感性和重复性良好,可用于大批量样本的临床检测和流行病学研究。

人参皂苷Rg3通过调控E2F1对人胃癌SGC-7901细胞生物行为学的影响

目的探究人参皂苷Rg3通过调控E2F1对人胃癌SGC-7901细胞生物行为学的影响。方法MTT测定不同浓度人参皂苷Rg3(0、80、160、320μmol·L^(-1))对细胞增殖影响;流式细胞术测定不同浓度人参皂苷Rg3对细胞凋亡的影响;划痕愈合实验和Transwell实验测定不同浓度人参皂苷Rg3对细胞迁移及侵袭的影响;Western blot测定不同浓度人参皂苷Rg3对E2F1、MMP-2、MMP-9、BCL-2、Bax表达的影响。结果80、160、320μmol·L^(-1)人参皂苷Rg3组细胞存活率与空白对照组比较明显降低,且呈浓度依赖性(P<0.05)。80、160、320μmol·L^(-1)人参皂苷Rg3组细胞凋亡率与空白对照组比较明显增加,且呈浓度依赖性(P<0.05)。80、160、320μmol·L^(-1)人参皂苷Rg3组细胞迁移数目与空白对照组比较明显降低,且呈浓度依赖性(P<0.05)。80、160、320μmol·L^(-1)人参皂苷Rg3组细胞侵袭数目与空白对照组比较明显降低,且呈浓度依赖性(P<0.05)。80、160、320μmol·L^(-1)人参皂苷Rg3组E2F1 mRNA与E2F1蛋白表达量相较空白对照组明显减少且,呈浓度依赖性(P<0.05)。80、160、320μmol·L^(-1)人参皂苷Rg3组细胞中MMP-2、MMP-9、BCL-2蛋白表达量与空白对照组比较明显降低,BCL-2与空白对照组比较明显升高,且呈浓度依赖性(P<0.05)。结论人参皂苷Rg3能降低胃癌SGC-7901细胞增殖能力,抑制细胞迁移及侵袭能力,同时还促进SGC-7901细胞凋亡,且具有浓度依赖性,其作用机制可能通过E2F1因子下调MMP-2、MMP-9、BCL-2表达,上调Bax表达有关。

载脂蛋白E联合临床相关指标预测阿尔兹海默病模型的建立与验证

目的 以载脂蛋白E(ApoE)为基础,结合阿尔茨海默病发病危险因素及临床常见指标,构建阿尔兹海默病发病风险的临床预测模型。方法 从南京市中医院大数据平台中,检索时间为2019年1月至2021年1月两年时间内,阿尔兹海默病患者61例,模糊匹配健康体检者111例。利用LASSO回归筛选危险因素,构建logistic回归预测模型,10折交叉进行区分度验证,bootstrap法进行校准度验证,临床决策曲线评判预测模型的临床指导性,最后以列线图可视化呈现临床预测模型。结果 筛选出12个变量,最终纳入4个危险因素:年龄、游离三碘甲状腺素(FT3)、性别、ApoE。全样本ROC曲线下面积为0.879,10折交叉9次验证后ROC曲线下平均面积为0.864;采用Bootstrap法抽样及Hosmer-Lemeshow校准度检验,结果χ^(2)=6.496,P=0.592>0.05。临床决策曲线阈值概率区间为1%~88.6%。结论 利用年龄、游离三碘甲状腺素、性别、 ApoE构建的临床预测模型对患者进行个体化评估,可以预警阿尔兹海默病,开展早期预防干预,减缓该病的发生发展。

肝喜片通过miR200a/ZEB信号通路抑制肝癌细胞HepG2上皮间质转化的机制研究

目的研究肝喜片通过微小分子RNA200a/E盒结合锌指蛋白(microRNA200a/zinc finger E-box binding homeobox,miR200a/ZEB)信号通路抑制肝癌细胞HepG2上皮间质转化的机制。方法培养肝癌细胞HepG2,制备肝喜片含药血清,采用不同浓度(10%、15%、20%)的肝喜片含药血清作用于HepG2细胞,同时设置空白对照组。运用CCK-8实验检测HepG2细胞的增殖,划痕实验、Transwell实验分别检测HepG2细胞的横向迁移和纵向迁移,Western blot检测ZEB1、ZEB2、E钙黏蛋白(E-cadherin)、波形蛋白(Vimentin)的表达,RT-PCR检测miR200a、ZEB1、ZEB2、E-cadherin、Vimentin mRNA的表达。结果与空白对照组比较,肝喜片各剂量组的细胞存活率显著降低,且具有明显的时间和浓度依赖性(P<0.05,P<0.01);肝喜片各剂量组的横向迁移率及纵向迁移细胞数显著减少(P<0.05,P<0.01)。与空白对照组比较,肝喜片中、高剂量组miR200a表达升高,肝喜片各剂量组E-cadherin蛋白及中、高剂量组E-cadherin mRNA表达升高,肝喜片各剂量组Vimentin蛋白及中、高剂量组Vimentin mRNA表达下降,肝喜片各剂量组ZEB1、ZEB2蛋白及mRNA表达下降(P<0.05,P<0.01);与肝喜片低剂量组比较,肝喜片中、高剂量组miR200a、E-cadherin蛋白及mRNA表达升高,Vimentin、ZEB1、ZEB2蛋白及mRNA表达下降(P<0.05,P<0.01);与肝喜片中剂量组比较,肝喜片高剂量组miR200a、E-cadherin蛋白及mRNA表达升高,Vimentin、ZEB1、ZEB2蛋白及mRNA表达下降(P<0.05,P<0.01)。结论肝喜片可显著抑制肝癌细胞HepG2的增殖和转移,其机制与调控miR200a/ZEB信号通路、促进E-hadherin的表达、抑制Vimentin的表达、逆转上皮间质转化相关。